ArticleVaccine2022
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5-11-year-olds in the United States.
Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- Efficacy, safety, and public attitude toward COVID-19 vaccines: A systematic review.Annals of African medicinePooled it
- Using a mental model approach to undercut the effects of exposure to mRNA vaccination misconceptions: Two randomized trials.Proceedings of the National Academy of Sciences of the United States of America · 2025Trial
- Balancing individual risks and collective benefits: Effects of vaccine price, message framing, and value orientations on influenza vaccination in China.Human vaccines & immunotherapeutics · 2026Article
- Untangling the Roots of HPV Vaccine Acceptance in West Virginia: How Hesitancy and Misinformation Shape Parental Decisions.Vaccines · 2026Article
- Accuracy and empathy of AI-based conversational chatbots in response to temporomandibular dysfunction related queries.PEC innovation · 2026Article
- Global Sentiment Toward Health AI at the Dawn of the ChatGPT Era: Empirical Analysis of Twitter (X) Discourse.Journal of medical Internet research · 2026Article
- Investigation of Youth Attitudes and Opinions Regarding HPV: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
- What can chatbot conversations reveal about vaccine concerns? An observational topic modelling study for public health infoveillance.BMJ digital health & AI · 2026Article
- Worry, risk perception, vaccine perception, and vaccine acceptance: Testing three competing path models in the context of COVID-19.Journal of public health research · 2025Article
- Article
- Considerations for mRNA Product Development, Regulation and Deployment Across the Lifecycle.Vaccines · 2025Review
- Article
- Experiences and perceptions about vaccines and reporting of adverse events following immunisation: a qualitative study among mothers in Northern Ghana.BMJ public health · 2025Article
- Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine.NPJ vaccines · 2024Article
- Article
- Latino Parents' Reactions to and Engagement With a Facebook Group-Based COVID-19 Vaccine Promotion Intervention: Mixed Methods Pilot Study.JMIR formative research · 2024Article
- Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.Vaccine · 2024Article
- Understanding caregivers' decision to vaccinate childhood cancer survivors against COVID-19.Cancer medicine · 2023Article
- Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.Vaccine: X · 2023Article
- Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19.Journal of Korean medical science · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite increasing rates of vaccination for COVID-19 in the US, hesitancy continues to be a barrier to the full immunization of the eligible population. Hesitancy appears to be particularly pronounced among adults deciding whether to recommend that children be vaccinated against COVID-19. In this research, we tested whether embrace of misinformation about the safety of vaccination is associated with hesitancy to vaccinate oneself and to recommend vaccination of a 5-11-year-old child for COVID-19. In a national probability panel created in April 2021, we assessed belief in both general vaccination misinformation and misinformation about COVID-19 vaccines, in particular. As hypothesized, belief in general vaccination misinformation predicted the uptake in reported vaccination among adults through September 2021, and likelihood to recommend COVID-19 vaccination of children aged 5-11 in January 2022, three months after the approval of that vaccine. In addition, misinformation about COVID-19 vaccines that arose over time correlated highly with more general vaccination misinformation. For both outcomes, general vaccine misinformation predicted vaccination hesitancy beyond concerns about the health risks of contracting COVID-19 for one's family and children ages 5-11. The findings indicate that continued efforts are needed to bolster beliefs about the safety of authorized and approved vaccines of many types and not just those for COVID-19. Some strategies to achieve this objective are suggested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.